Advertisement
Advertisement

PPBT

PPBT logo

Purple Biotech Ltd. - ADR

1.50
USD
Sponsored
+0.07
+4.90%
Aug 10, 15:59 UTC -4
Closed
exchange

After-Market

1.46

-0.04
-2.60%

Purple Biotech Ltd. - ADR Profile

About

Purple Biotech Ltd. is a clinical-stage company focusing on therapies to overcome tumor immune evasion and drug resistance. The Company's oncology pipeline includes NT219 and CM24. Purple Biotech Ltd., formerly known as Kitov Pharma Ltd., is based in TEL AVIV, Israel.

Info & Links

CEO

Gil Efron

Headquarters

4 OPPENHEIMER STREET, SCIENCE PARK
REHOVOT, L3 7670104, ISRAEL

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.purple-biotech.com

Auditor

Somekh Chaikin

Share holders

--

Employees

10

Purple Biotech Ltd. - ADR Statistics

Valuation Measures

Market Capitalization2

2.38M

Enterprise Value

-3.19M

Enterprise Value/EBITDA(ttm)

0.11

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.14

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-136.79%

Return on Invested Capital(ttm)

-253.06%

Return on Assets(ttm)

-100.38%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-28.08M

Net Income Available to Common(ttm)

-26.02M

Diluted EPS(ttm)

-23.25

Share Statistics

Beta (5Y Monthly)

0.67

52-Week Change

-92.96%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

901.00K

% Held by Insiders

2.98%

% Held by Institutions

9.64%

Balance Sheet

Total Cash(mrq)

6.43M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.48%

Quick Ratio(mrq)

1.48%

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.35

Free Cash Flow(ytd)

-3.12M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement